Revenue contracted 10.9% year-over-year in Q2 2026, yet the combined ratio improved to 93.6% in Q1 2026, indicating stable underwriting profitability despite legacy runoff.
Genworth Financial, Inc. (GNW) annual income statement — 24-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 |
|---|
| Revenue | 6.99B | 6.37B | 7.14B | 7.37B | 7.4B | 7.6B | 8.21B | 7.71B | 7.89B | 7.51B | 8.36B | 8.55B | 8.73B | 8.63B | 9.64B | 9.92B | 10.09B | 9.07B | 9.95B | 11.13B | 10.29B | 9.79B | 10.37B | 11B | 11.23B |
| Revenue Growth % | -1.15% | -10.86% | -3.09% | -0.34% | -2.67% | -7.46% | 6.57% | -2.33% | 5.02% | -10.16% | -2.16% | -2.07% | 1.21% | -10.53% | -2.85% | -1.65% | 11.25% | -8.84% | -10.58% | 8.17% | 5.1% | -5.6% | -5.74% | -2.06% | - |
| Medical Costs & Claims | 4.15B | 4.82B | 6.58B | 7.07B | 6.02B | 6.55B | 7.16B | 6.95B | 7.51B | 7.12B | 7.71B | 8.14B | 8.75B | 7.18B | 8.47B | 9.26B | 9.69B | 8.69B | 9.26B | 8.21B | 6.02B | 5.57B | 1.81B | 1.94B | 0 |
| Medical Cost Ratio % | 59.37% | 75.72% | 92.19% | 95.88% | 81.45% | 86.2% | 87.2% | 90.23% | 95.16% | 94.77% | 92.22% | 95.27% | 100.19% | 83.27% | 87.85% | 93.3% | 96% | 95.78% | 93.07% | 73.77% | 58.5% | 56.96% | 17.48% | 17.66% | 0% |
| Gross Profit | 2.84B | 1.55B | 558M | 304M | 1.37B | 1.05B | 1.05B | 753M | 382M | 393M | 651M | 404M | -17M | 1.44B | 1.17B | 665M | 404M | 383M | 689M | 2.92B | 4.27B | 4.21B | 8.55B | 9.06B | 11.23B |
| Gross Margin % | 40.63% | 24.28% | 7.81% | 4.12% | 18.55% | 13.8% | 12.8% | 9.77% | 4.84% | 5.23% | 7.78% | 4.73% | -0.19% | 16.73% | 12.15% | 6.7% | 4% | 4.22% | 6.93% | 26.23% | 41.5% | 43.04% | 82.52% | 82.34% | 100% |
| Gross Profit Growth % | - | 177.06% | 83.55% | -77.84% | 30.79% | -0.19% | 39.57% | 97.12% | -2.8% | -39.63% | 61.14% | 2476.47% | -101.18% | 23.23% | 76.09% | 64.6% | 5.48% | -44.41% | -76.39% | -31.63% | 1.33% | -50.77% | -5.53% | -19.35% | - |
| Operating Expenses | 2.44B | 1.11B | -37M | 1M | 7M | -63M | 123M | 231M | 245M | 266M | 331M | 419M | 1.28B | 450M | 565M | 535M | 457M | 1.18B | 1.63B | 1.31B | 2.42B | 2.47B | 6.97B | 7.75B | 9.44B |
| OpEx / Revenue % | 34.88% | 17.48% | -0.52% | 0.01% | 0.09% | -0.83% | 1.5% | 3% | 3.11% | 3.54% | 3.96% | 4.9% | 14.69% | 5.22% | 5.86% | 5.39% | 4.53% | 12.96% | 16.4% | 11.79% | 23.48% | 25.21% | 67.24% | 70.48% | 84.05% |
| Depreciation & Amortization | 55M | 93M | 130M | 40M | 0 | 0 | 0 | 557M | 269M | 288M | 360M | 0 | 0 | 0 | 0 | 743M | 756M | 782M | 884M | 831M | 702M | 809M | 1.15B | 1.35B | 1.22B |
| Combined Ratio % | 94.25% | 93.2% | 91.67% | 95.89% | 81.54% | 85.37% | 88.7% | 93.23% | 98.26% | 98.31% | 96.17% | 100.18% | 114.88% | 88.49% | 93.71% | 98.69% | 100.53% | 108.73% | 109.47% | 85.56% | 81.98% | 82.17% | 84.72% | 88.13% | 84.05% |
| Operating Income | 402M | 433M | 595M | 303M | 1.36B | 1.11B | 928M | 522M | 137M | 127M | 320M | -15M | -1.3B | 993M | 606M | 130M | -53M | -792M | -942M | 1.61B | 1.85B | 1.75B | 1.58B | 1.3B | 1.79B |
| Operating Margin % | 5.75% | 6.8% | 8.33% | 4.11% | 18.46% | 14.63% | 11.3% | 6.77% | 1.74% | 1.69% | 3.83% | -0.18% | -14.88% | 11.51% | 6.29% | 1.31% | -0.53% | -8.73% | -9.47% | 14.44% | 18.02% | 17.83% | 15.28% | 11.87% | 15.95% |
| Operating Income Growth % | - | -27.23% | 96.37% | -77.8% | 22.75% | 19.83% | 77.78% | 281.02% | 7.87% | -60.31% | 2233.33% | 98.85% | -230.82% | 63.86% | 366.15% | 345.28% | 93.31% | 15.92% | -158.66% | -13.33% | 6.19% | 10.16% | 21.38% | -27.14% | - |
| EBITDA | 536M | 526M | 725M | 343M | 1.47B | 1.27B | 1.12B | 1.08B | 406M | 415M | 680M | 404M | -866M | 1.44B | 1.08B | 873M | 703M | -10M | -58M | 2.44B | 2.56B | 2.55B | 2.73B | 2.66B | 3.01B |
| EBITDA Margin % | 7.67% | 8.26% | 10.15% | 4.65% | 19.89% | 16.74% | 13.68% | 14% | 5.15% | 5.52% | 8.13% | 4.73% | -9.92% | 16.73% | 11.22% | 8.8% | 6.97% | -0.11% | -0.58% | 21.91% | 24.84% | 26.1% | 26.32% | 24.15% | 26.82% |
| Interest Expense | 104M | 105M | 115M | 118M | 106M | 160M | 195M | 231M | 256M | 266M | 337M | 419M | 433M | 450M | 476M | 506M | 457M | 393M | 470M | 481M | 1.88B | 1.72B | 1.65B | 1.76B | 1.77B |
| Non-Operating Income | -104M | -105M | -115M | -118M | -106M | -160M | -195M | -230M | -256M | -266M | -337M | -419M | -433M | -450M | -476M | -506M | -457M | -393M | -470M | -481M | -1.88B | -1.72B | -1.7B | -1.84B | -1.77B |
| Pretax Income | 402M | 433M | 595M | 303M | 1.36B | 1.11B | 928M | 521M | 137M | 127M | 320M | -15M | -1.3B | 993M | 606M | 130M | -53M | -792M | -942M | 1.61B | 1.85B | 1.75B | 1.58B | 1.3B | 1.79B |
| Pretax Margin % | 5.75% | 6.8% | 8.33% | 4.11% | 18.46% | 14.63% | 11.3% | 6.76% | 1.74% | 1.69% | 3.83% | -0.18% | -14.88% | 11.51% | 6.29% | 1.31% | -0.53% | -8.73% | -9.47% | 14.44% | 18.02% | 17.83% | 15.28% | 11.87% | 15.95% |
| Income Tax | 70M | 84M | 158M | 104M | 319M | 248M | 230M | 139M | 70M | -406M | 358M | -9M | -94M | 313M | 138M | -11M | -248M | -393M | -370M | 452M | 570M | 559M | 475M | 384M | 411M |
| Effective Tax Rate % | 17.41% | 19.4% | 26.55% | 34.32% | 23.37% | 22.3% | 24.78% | 26.68% | 51.09% | -319.69% | 111.87% | 60% | 7.24% | 31.52% | 22.77% | -8.46% | 467.92% | 49.62% | 39.28% | 28.14% | 30.76% | 32.03% | 29.99% | 29.43% | 22.95% |
| Net Income | 212M | 223M | 299M | 76M | 916M | 850M | 178M | 343M | 119M | 817M | -277M | -615M | -1.24B | 560M | 325M | 38M | 52M | -460M | -572M | 1.22B | 1.33B | 1.22B | 1.16B | 1.08B | 1.17B |
| Net Margin % | 3.03% | 3.5% | 4.19% | 1.03% | 12.39% | 11.19% | 2.17% | 4.45% | 1.51% | 10.87% | -3.31% | -7.19% | -14.25% | 6.49% | 3.37% | 0.38% | 0.52% | -5.07% | -5.75% | 10.97% | 12.91% | 12.48% | 11.16% | 9.83% | 10.46% |
| Net Income Growth % | 12.17% | -25.42% | 293.42% | -91.7% | 7.76% | 377.53% | -48.1% | 188.24% | -85.43% | 394.95% | 54.96% | 50.56% | -322.14% | 72.31% | 755.26% | -26.92% | 111.3% | 19.58% | -146.89% | -8.13% | 8.76% | 5.53% | 7.03% | -7.92% | - |
| EPS (Diluted) | 0.55 | 0.54 | 0.68 | 0.16 | 1.19 | 1.76 | 1.49 | 1.02 | 0.24 | 1.63 | -0.56 | -1.24 | -2.51 | 1.12 | 0.66 | 0.08 | 0.11 | -1.02 | -1.32 | 2.73 | 2.83 | 2.52 | 2.26 | 1.88 | 2.42 |
| EPS Growth % | 19.5% | -20.59% | 325% | -86.55% | -32.39% | 18.12% | 46.08% | 325% | -85.28% | 391.07% | 54.84% | 50.6% | -324.11% | 69.7% | 725% | -27.27% | 110.78% | 22.73% | -148.35% | -3.53% | 12.3% | 11.5% | 20.21% | -22.31% | - |
| EPS (Basic) | - | 0.55 | 0.69 | 0.16 | 1.21 | 1.78 | 1.51 | 1.03 | 0.24 | 1.64 | -0.56 | -1.24 | -2.51 | 1.13 | 0.66 | 0.08 | 0.11 | -1.02 | -1.32 | 2.77 | 2.91 | 2.57 | 2.27 | 1.88 | 2.42 |
| Diluted Shares Outstanding | 386.3M | 414M | 439.4M | 474.9M | 511M | 514.7M | 511.6M | 509.7M | 500.4M | 501.4M | 498.3M | 497.4M | 496.4M | 498.7M | 494.4M | 493.5M | 493.9M | 451.1M | 433.2M | 447.6M | 469.4M | 484.6M | 490.5M | 489.5M | 485.71M |
Quick answers to the most common questions about buying GNW stock.
For fiscal year 2025, Genworth Financial, Inc. (GNW) reported total revenue of $6.37B. This represents a 43.3% decline compared to $11.23B in 2002.
Genworth Financial, Inc. (GNW) is profitable, generating $223.0M in net income for the fiscal year ending 2025 with a net profit margin of 3.5%.
Genworth Financial, Inc. (GNW) reported an operating income of $433.0M, resulting in an operating profit margin of 6.8%. This margin reflects the operational efficiency of the business before interest and taxes.
Genworth Financial, Inc. (GNW) generated $1.55B in gross profit for the year, representing a gross profit margin of 24.3%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Legacy LTC reserve volatility
Metrics are mathematically derived from official filings.
Premium Base Shrinks Amid Legacy Runoff
Genworth's total revenue contracted 10.9% year-over-year in Q2 2026, reflecting continued runoff in legacy life blocks and subdued mortgage insurance volumes, as reported in the latest quarterly filing.
The persistent negative revenue growth, with quarterly declines ranging from -0.3% to -13.3% over the past year, suggests that the company is not generating organic growth from its core segments. The Enact segment, while profitable, faces headwinds from high interest rates dampening mortgage origination volumes, while the U.S. Life segment's premium base continues to shrink as policies lapse or are run off. This trajectory implies that future earnings will increasingly depend on cost management and investment income rather than top-line expansion.
Underwriting Discipline Keeps Combined Ratio in Check
The combined ratio has remained below 100% for the last five quarters, with Q1 2026 at 93.6%, indicating consistent underwriting profitability, according to Genworth's financial statements.
Despite the revenue decline, the combined ratio has stayed in the low-to-mid 90s, suggesting that the company is effectively managing claims and expenses. The loss ratio, which spiked to 98.7% in Q4 2024, has since improved to 71.0% in Q1 2026, likely reflecting favorable reserve development or lower catastrophe losses. However, the operating margin of 6.8% is thin compared to peers like Radian (61.2%) and Essent (65.2%), highlighting that Genworth's profitability is constrained by its legacy life operations, which require significant reserve funding.
Reserve Releases Bolster Recent Earnings
Net income in Q3 2025 jumped to $116 million, with EPS of $0.28, likely aided by favorable prior-year reserve development, as indicated by the low loss ratio of 93.1% that quarter.
The volatility in net income, swinging from a loss of $1 million in Q4 2024 to a gain of $116 million in Q3 2025, suggests that reserve adjustments are a significant earnings driver. The low loss ratios in recent quarters may reflect releases from prior-year reserves, which can inflate current earnings without improving the underlying business. Investors should monitor the quality of earnings, as reliance on reserve releases may not be sustainable, especially if long-term care claims experience deteriorates.
Investment Income Supports Bottom Line
With investment income not separately disclosed, but the company's $2.036 billion cash position and large fixed-income portfolio likely provide a stable yield, contributing to overall profitability, as per the balance sheet.
Given the long-duration liabilities of the life segment, investment income is a critical component of earnings. In a rising rate environment, reinvestment yields may improve, potentially easing pressure on reserves. However, the lack of explicit investment income data in the provided figures limits a detailed analysis. The company's ability to generate sufficient investment returns to match its liability obligations remains a key risk, particularly if interest rates decline or credit spreads widen.
Expense Ratio Reflects Legacy Complexity
The expense ratio, implied by the combined ratio and loss ratio, appears elevated, with Q1 2026 at 22.6%, indicating high fixed costs from managing legacy blocks, based on reported figures.
The expense ratio, calculated as the difference between the combined ratio and loss ratio, has been consistently above 20%, which is high compared to pure-play mortgage insurers like MGIC (expense ratio around 15%). This reflects the administrative burden of servicing a large, closed block of long-term care policies and the costs of regulatory compliance. While management has focused on de-risking, the expense base remains sticky, limiting margin expansion potential.
Earnings Quality Questioned by Revenue Decline
Despite an EPS beat in Q2 2026, revenue fell 10.9% year-over-year, and the absence of forward guidance raises concerns about the sustainability of earnings, as noted in the earnings release.
The positive EPS surprise may be driven by one-time items or cost cuts rather than underlying business strength. The lack of guidance suggests management's uncertainty about future performance, which is concerning given the ongoing runoff of legacy blocks. Additionally, the company's low debt/equity ratio of 0.15% indicates financial flexibility, but it also implies that management is not leveraging the balance sheet for growth, possibly due to limited attractive opportunities. Investors should question whether the current earnings level is sustainable without continued reserve releases or significant rate increases on LTC policies.